Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Basic Sciences

Endogenous Retroviral env Genes after N-Methyl-N′-nitro-N-nitrosoguanidine Treatment of Mouse Tumor Cells: Stable DNA Amplification and Rearrangement

Doris Apt, Jeanette Schreck and Peter Altevogt
Doris Apt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanette Schreck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Altevogt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published July 1989
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Immunogenic tumor variant clones derived by N-methyl-N′-nitro-N-nitrosoguanidine treatment of Eb lymphoma cells showed structurally altered gp70 env proteins at the cell surface. To further investigate this observation we screened for complementary DNA clones encoding gp70 antigens from a λ gt11 expression library constructed from mRNA of a mutant cell clone. Using gp70-specific antibodies, a total of 10 complementary DNA clones were identified and analyzed. DNA-sequence analysis revealed the presence of both xeno/or mink cell focus-forming-type (clones 1, 10) and endogenous ecotropic gp70 (clones 2, 3, 4). Southern blot experiments using clone 2 as a probe detected new restriction fragments and DNA amplification with high copy number in the DNAs of N-methyl-N′-nitro-N-nitrosoguanidine-treated but not in parental or 5′-azacytidine-treated control cells even after > 120 days in tissue culture. No alterations in the restriction fragment pattern of the genomic DNAs could be detected using H-2K-, β-actin-, or dehydrofolate-reductasespecific gene probes. The DNA amplification of specific gp70 sequences may be related to the enhanced expression of a subset of gp70 in mutant cells that was previously found to induce syngeneic antibody production.

Footnotes

  • ↵1 This work was supported by a grant from Deutsche Forschungsgemeinschaft (Al 170/3-2).

  • ↵2 To whom requests for reprints should be addressed, at the Institute for Immunology and Genetics, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900 Heidelberg, FRG.

  • Received October 28, 1988.
  • Revision received February 28, 1989.
  • Accepted April 18, 1989.
  • ©1989 American Association for Cancer Research.
PreviousNext
Back to top
July 1989
Volume 49, Issue 14
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Endogenous Retroviral env Genes after N-Methyl-N′-nitro-N-nitrosoguanidine Treatment of Mouse Tumor Cells: Stable DNA Amplification and Rearrangement
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Endogenous Retroviral env Genes after N-Methyl-N′-nitro-N-nitrosoguanidine Treatment of Mouse Tumor Cells: Stable DNA Amplification and Rearrangement
Doris Apt, Jeanette Schreck and Peter Altevogt
Cancer Res July 15 1989 (49) (14) 3966-3971;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Endogenous Retroviral env Genes after N-Methyl-N′-nitro-N-nitrosoguanidine Treatment of Mouse Tumor Cells: Stable DNA Amplification and Rearrangement
Doris Apt, Jeanette Schreck and Peter Altevogt
Cancer Res July 15 1989 (49) (14) 3966-3971;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • T-Cell Receptor Vβ Gene Expression Differs in Tumor-infiltrating Lymphocytes within Primary and Metastatic Melanoma
  • Laminin Receptor Complementary DNA-deduced Synthetic Peptide Inhibits Cancer Cell Attachment to Endothelium
  • Acidic and Basic Fibrolast Growth Factors Are Present in Glioblastoma Multiforme
Show more 3

Articles

  • T-Cell Receptor Vβ Gene Expression Differs in Tumor-infiltrating Lymphocytes within Primary and Metastatic Melanoma
  • Laminin Receptor Complementary DNA-deduced Synthetic Peptide Inhibits Cancer Cell Attachment to Endothelium
  • Acidic and Basic Fibrolast Growth Factors Are Present in Glioblastoma Multiforme
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement